SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients

Clinical trial NCT00274105 · TERMINATED

Trial details

NCT number: NCT00274105
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Coronary Arteriosclerosis

Start date: 2001-03-01
Primary completion: 2004-10-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.